Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine
Kaohsiung, Taiwan
位於高雄的綜合醫院
About Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine
"Kaohsiung CGMH NeuroScience Lab MRI and PET schedule"
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Panion & BF Biotech Inc.
3
Clinical Trials at Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine
During the past decade, Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations
A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
2020-03-04
2025-02-21
Recruiting
660
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine
According to Clinical.Site data, the most researched conditions in "Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine" are
"Hepatitis B, Chronic" (2 trials), "Hyperphosphatemia" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Anemia of Chronic Kidney Disease" (1 trials) and "ESRD" (1 trials). Many other conditions were trialed in "Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine
Most popular intervention types in "Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials), "Gemcitabine" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine
The vast majority of trials in "Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine" are
9 trials for "All" genders.
Clinical Trials Status at Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine
Currently, there are NaN active trials in "Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kaohsiung Chang Gung Memorial Hospital; Dept of Internal Medicine, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".